» Articles » PMID: 37063367

The Potential Therapeutic Roles of Rho GTPases in Substance Dependence

Overview
Specialty Molecular Biology
Date 2023 Apr 17
PMID 37063367
Authors
Affiliations
Soon will be listed here.
Abstract

Rho GTPases family are considered to be molecular switches that regulate various cellular processes, including cytoskeleton remodeling, cell polarity, synaptic development and maintenance. Accumulating evidence shows that Rho GTPases are involved in neuronal development and brain diseases, including substance dependence. However, the functions of Rho GTPases in substance dependence are divergent and cerebral nuclei-dependent. Thereby, comprehensive integration of their roles and correlated mechanisms are urgently needed. In this review, the molecular functions and regulatory mechanisms of Rho GTPases and their regulators such as GTPase-activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs) in substance dependence have been reviewed, and this is of great significance for understanding their spatiotemporal roles in addictions induced by different addictive substances and in different stages of substance dependence.

Citing Articles

Integrating Drug Target Information in Deep Learning Models to Predict the Risk of Adverse Events in Patients with Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder.

Miranda O, Qi X, Brannock M, Whitworth R, Kosten T, Ryan N Biomedicines. 2025; 12(12.

PMID: 39767679 PMC: 11673068. DOI: 10.3390/biomedicines12122772.


Divergent gene expression patterns in alcohol and opioid use disorders lead to consistent alterations in functional networks within the dorsolateral prefrontal cortex.

MacDonald M, Fonseca P, Johnson K, Murray E, Kember R, Kranzler H Transl Psychiatry. 2024; 14(1):437.

PMID: 39402051 PMC: 11473550. DOI: 10.1038/s41398-024-03143-z.


Sex-specific Concordance of Striatal Transcriptional Signatures of Opioid Addiction in Human and Rodent Brains.

Logan R, Shelton M, Horan N, Xue X, Maturin L, Eacret D Res Sq. 2024; .

PMID: 39399686 PMC: 11469374. DOI: 10.21203/rs.3.rs-5006061/v1.


Substance Addiction Rehabilitation Drugs.

Yuan S, Jiang S, Zhang Z, Li Z, Hu J Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794185 PMC: 11124501. DOI: 10.3390/ph17050615.


Decoding cocaine-induced proteomic adaptations in the mouse nucleus accumbens.

Mews P, Sosnick L, Gurung A, Sidoli S, Nestler E Sci Signal. 2024; 17(832):eadl4738.

PMID: 38626009 PMC: 11170322. DOI: 10.1126/scisignal.adl4738.

References
1.
Paskus J, Herring B, Roche K . Kalirin and Trio: RhoGEFs in Synaptic Transmission, Plasticity, and Complex Brain Disorders. Trends Neurosci. 2020; 43(7):505-518. PMC: 7321888. DOI: 10.1016/j.tins.2020.05.002. View

2.
Kurt A, Macit E, Uzbay T, Buyukafsar K . Effects of ethanol withdrawal on the activity of rho-kinase in rat brain. Bratisl Lek Listy. 2015; 116(8):490-3. DOI: 10.4149/bll_2015_093. View

3.
Wang Q, Chen M, Schafer N, Bueno C, Song S, Hudmon A . Assemblies of calcium/calmodulin-dependent kinase II with actin and their dynamic regulation by calmodulin in dendritic spines. Proc Natl Acad Sci U S A. 2019; 116(38):18937-18942. PMC: 6754556. DOI: 10.1073/pnas.1911452116. View

4.
Koch J, Tatenhorst L, Roser A, Saal K, Tonges L, Lingor P . ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol Ther. 2018; 189:1-21. DOI: 10.1016/j.pharmthera.2018.03.008. View

5.
Xueyang D, Zhanqiang M, Chunhua M, Kun H . Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure. Oncotarget. 2016; 7(48):78764-78772. PMC: 5346675. DOI: 10.18632/oncotarget.12853. View